PBYI - Puma Biotechnology - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

Puma Biotechnology's activity chart (see below) currently has 21 price targets and 20 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 62.41% with an average time for these price targets to be met of 190.71 days.

Most recent stock forecast was given by from HC WAINWRIGHT on 28-Feb-2025. First documented stock forecast 02-Feb-2015.

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 06-Dec-2019

$7

$-1.11 (-13.69%)

1 years 4 months 15 days ago
(28-Feb-2025)

16/17 (94.12%)

$3.42 (95.53%)

749

Hold Since 10-May-2019

$4

$-3.78 (-48.59%)

2 years 8 months 10 days ago
(03-Nov-2023)

2/7 (28.57%)

$1.22 (43.88%)

48

Sell Since 02-Nov-2018

$5

$-2.78 (-35.73%)

$6

4 years 8 months 8 days ago
(05-Nov-2021)

4/7 (57.14%)

$0.99 (24.69%)

296

Hold Since 07-Jun-2019

$11

$3.22 (41.39%)

$11

4 years 9 months 16 days ago
(27-Sep-2021)

14/23 (60.87%)

$3.88 (54.49%)

204

Hold Since 06-Dec-2018

$6

$-1.78 (-22.88%)

4 years 11 months 7 days ago
(06-Aug-2021)

8/9 (88.89%)

$-1.1 (-15.49%)

133

Show more analysts

Please expand the browser size to see the chart

What is PBYI (Puma Biotechnology) average time for price targets to be met?

On average it took 190.71 days on average for the stock forecasts to be realized with a an average price target met ratio 62.41

Which analyst has the current highest performing score on PBYI (Puma Biotechnology) with a proven track record?

YIGAL NOCHOMOVITZ

Which analyst has the most public recommendations on PBYI (Puma Biotechnology)?

Yigal Nochomovitz works at CITI and has 29 price targets and 20 ratings on PBYI

Which analyst is the currently most bullish on PBYI (Puma Biotechnology)?

Thomas Shrader with highest potential upside - $122.22

Which analyst is the currently most reserved on PBYI (Puma Biotechnology)?

Chris Shibutani with lowest potential downside - -$3.78

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?